Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Identification of Novel Somatic Mutations, Regions of Recurrent Loss of Heterozygosity (LOH) and Significant Clonal Evolution From Diagnosis to Relapse in Childhood AML Determined by Exome Capture Sequencing – an NCI/COG Target AML Study

Soheil Meshinchi, MD, PhD, Rhonda E. Ries, MA, Lisa R. Trevino, PhD, Oliver A. Hampton, PhD, Todd Alonzo, PhD, Jason E. Farrar, MD, Jaime M. Guidry Auvil, PhD, Tanja M. Davidsen, PhD, Patee Gesuwan, PhD, Donna M. Muzny, Alan S. Gamis, MD, MPH, Heather L. Helton, MD, David A. Wheeler, PhD, Malcolm A. Smith, MD, PhD, Daniela S. Gerhard, Ph.D., Robert J. Arceci, MD, PhD

Blood (2012) 120 (21): 123.

https://doi.org/10.1182/blood.V120.21.123.123

Published: 2012

Journal Articles

High EVI1 expression Is Associated with MLL rearrangements and Predicts Decreased Survival in Pediatric AML: A Report From the Children's Oncology Group.

Phoenix A. Ho, MD, Todd Alonzo, PhD, Robert B. Gerbing, M.A., Jessica A. Pollard, MD, Susana C. Raimondi, Betsy A. Hirsch, PhD, Todd Cooper, DO, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2012) 120 (21): 2530.

https://doi.org/10.1182/blood.V120.21.2530.2530

Published: 2012

Journal Articles

Clinical and Serologic Interleukin 2 Receptor α Response to Interleukin-2 in CCG-2961, a Ranomized Phase 3 Trial for Pediatric Acute Myeloid Leukemia.

Beverly Lange, MD, Richard K Yang, Jacek Gan, PhD, Jaqueline A Hank, PhD, Eric Sievers, MD, Robert Gerbing, Todd Alonzo, PhD, Paul M Sondel, MD, PhD

Blood (2008) 112 (11): 959.

https://doi.org/10.1182/blood.V112.11.959.959

Published: 2008

Journal Articles

Pediatric Patients with Extramedullary Leukemia Involving the Central Nervous System Have a Superior Outcome.

Donna Johnston, MD, FRCPC, Todd Alonzo, PhD, Robert Gerbing, Beverly Lange, MD, William G. Woods, MD

Blood (2008) 112 (11): 920.

https://doi.org/10.1182/blood.V112.11.920.920

Published: 2008

Journal Articles

Functional Polymorphisms in Oxidant Metabolism and DNA Repair Pathways and Risk of Leukemia and Transient Myeloproliferative Disorder in Children with Down Syndrome

Melissa S Rayburg, MD, Mi-Ok Kim, Todd Alonzo, PhD, Robert Gerbing, Gretchen A Radloff, Stella M Davies, Alan Gamis, MD, John Perentesis

Blood (2008) 112 (11): 2947.

https://doi.org/10.1182/blood.V112.11.2947.2947

Published: 2008

Journal Articles

COG AAML03P1: Efficacy and Safety in a Pilot Study of Intensive Chemotherapy Including Gemtuzumab in Children Newly Diagnosed with Acute Myeloid Leukemia (AML)

Janet Franklin, MD, MPH, Todd Alonzo, PhD, Craig Alan Hurwitz, MD, Robert Gerbing, Franklin Smith, Robert J. Arceci, MD, PhD, James Feusner, MD, Prasad Mathew, MD, Robert Iannone, MD, Soheil Meshinchi, MD, PhD, Robert Lavey, MD, MPH, Joetta D Wallace, RN, Kelly Anderson, RN, Laura Winter, PharmD, Kathleen Glick, BA, Betty Hirsch, MD, Susana C. Raimondi, PhD, Alan Gamis, MD

Blood (2008) 112 (11): 136.

https://doi.org/10.1182/blood.V112.11.136.136

Published: 2008

Journal Articles

High Level Expression of Wild Type FLT3 Is Associated with Poor Outcome and Selective Sensitivity to FLT3 Inhibitors in Childhood Acute Myeloid Leukemia: A Children’s Oncology Group Study

Patrick Brown, MD, Todd Alonzo, PhD, Robert Gerbing, Emily McIntyre, Beverly Lange, MD, Donald Small, Soheil Meshinchi, MD, PhD

Blood (2008) 112 (11): 147.

https://doi.org/10.1182/blood.V112.11.147.147

Published: 2008

Journal Articles

Prevalence and Prognostic Implications of WT1 Mutations in Pediatric AML Â: Report from Children’s Oncology Group

Jessica A Pollard, Rong Zeng, Phoenix Ho, Todd Alonzo, PhD, Robert Gerbing, Derek Stirewalt, Nyla A. Heerema, PhD, Susana C. Raimondi, PhD, Betsy Hirsch, Janet Franklin, MD, MPH, Beverly Lange, MD, Soheil Meshinchi, MD, PhD

Blood (2008) 112 (11): 143.

https://doi.org/10.1182/blood.V112.11.143.143

Published: 2008

Journal Articles

Correlation of CD 33 Expression Level with Disease Characteristics and Response to Gemtuzumab Ozogamycin-Containing Chemotherapy in Childhood AML

Jessica A Pollard, Todd Alonzo, PhD, Robert Gerbing, Susana C. Raimondi, PhD, Betsy Hirsch, Janet Franklin, MD, MPH, Alan Gamis, MD, Michael R Loken, Soheil Meshinchi, MD, PhD

Blood (2008) 112 (11): 148.

https://doi.org/10.1182/blood.V112.11.148.148

Published: 2008

Journal Articles

Cell Death Regulatory Gene Expression Correlates with MLL Rearrangement Status and Prognostic Clinical Covariates in Acute Leukemia in Infants.

Alena Y. Zhang, PharmD, PhD, Blaine W. Robinson, PhD, Kajia Kao, PhD, Kathryn Behling, MD, PhD, Meenakshi Devidas, PhD, Todd Alonzo, PhD, Susana C. Raimondi, PhD, Andrew Carroll, PhD, Robert J. Arceci, MD, PhD, Alan Gamis, MD, Stephen P. Hunger, MD, Gregory H. Reaman, MD, Richard C. Harvey, PhD, Cheryl L. Willman, MD, Li-San Wang, PhD, Carolyn A. Felix, MD

Blood (2008) 112 (11): 2255.

https://doi.org/10.1182/blood.V112.11.2255.2255

Published: 2008

Journal Articles

Minimal Residual Disease Detection by Four-Color Multidimensional Flow Cytometry Identifies Pediatric AML Patients at High Risk of Relapse.

Soheil Meshinchi, MD, PhD, Todd Alonzo, PhD, Robert B. Gerbing, MA, Jessica A. Pollard, MD, Alan S. Gamis, MD, MPH, Craig A. Hurwitz, MD, Janet L. Franklin, MD, Laura Pardo, MD, Michael Loken, PhD

Blood (2007) 110 (11): 1429.

https://doi.org/10.1182/blood.V110.11.1429.1429

Published: 2007

Journal Articles

Obesity in Newly Diagnosed Childhood Acute Promyelocytic Leukemia.

James Feusner, MD, Haesook Kim, PhD, John Gregory, MD, Todd Alonzo, PhD, William Woods, MD, Howard Weinstein, MD, Martin Tallman, MD

Blood (2006) 108 (11): 4494.

https://doi.org/10.1182/blood.V108.11.4494.4494

Published: 2006

NARROW

Identification of Novel Somatic Mutations, Regions of Recurrent Loss of Heterozygosity (LOH) and Significant Clonal Evolution From Diagnosis to Relapse in Childhood AML Determined by Exome Capture Sequencing – an NCI/COG Target AML Study

High EVI1 expression Is Associated with MLL rearrangements and Predicts Decreased Survival in Pediatric AML: A Report From the Children's Oncology Group.

Clinical and Serologic Interleukin 2 Receptor α Response to Interleukin-2 in CCG-2961, a Ranomized Phase 3 Trial for Pediatric Acute Myeloid Leukemia.

Pediatric Patients with Extramedullary Leukemia Involving the Central Nervous System Have a Superior Outcome.

Functional Polymorphisms in Oxidant Metabolism and DNA Repair Pathways and Risk of Leukemia and Transient Myeloproliferative Disorder in Children with Down Syndrome

COG AAML03P1: Efficacy and Safety in a Pilot Study of Intensive Chemotherapy Including Gemtuzumab in Children Newly Diagnosed with Acute Myeloid Leukemia (AML)

High Level Expression of Wild Type FLT3 Is Associated with Poor Outcome and Selective Sensitivity to FLT3 Inhibitors in Childhood Acute Myeloid Leukemia: A Children’s Oncology Group Study

Prevalence and Prognostic Implications of WT1 Mutations in Pediatric AML Â: Report from Children’s Oncology Group

Correlation of CD 33 Expression Level with Disease Characteristics and Response to Gemtuzumab Ozogamycin-Containing Chemotherapy in Childhood AML

Cell Death Regulatory Gene Expression Correlates with MLL Rearrangement Status and Prognostic Clinical Covariates in Acute Leukemia in Infants.

Minimal Residual Disease Detection by Four-Color Multidimensional Flow Cytometry Identifies Pediatric AML Patients at High Risk of Relapse.

Obesity in Newly Diagnosed Childhood Acute Promyelocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only